Translational Research

Researchers in the lab of Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research, have added BI-0474 as the second molecule co-discovered by Vanderbilt to the open science portal opnMe.com, an initiative being driven by biopharmaceutical company Boehringer Ingelheim. Read More

Vanderbilt University Medical Center’s vibrant culture of clinical and translational research was celebrated at an annual forum last week, and two physician-scientist leaders were honored with awards. Read More

Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently. Read More

To ease data collection for clinical research and ongoing analysis of clinical processes, teams at Vanderbilt University Medical Center (VUMC) are working to bridge the gap between clinical systems and research systems. Read More

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). Read More

The Vanderbilt Center for Quality Aging is taking the “bench to bedside” concept of translational research out into the community, forming partnerships with assisted living facilities to examine how evidence can be put into action to improve the care of elders. Read More

The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia. Read More